{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-021303","form_type":"8-K","ticker":"RKDA","cik":"0001469443","company_name":"Arcadia Biosciences, Inc.","filed_at":"2023-05-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.960274+00:00","generated_at":"2026-06-15T03:58:00.075716+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Arcadia Biosciences Q1 revenue $1.5M (down 53% YoY) but gross profit improves $922k","bullets":["Total revenues $1.5M vs $3.2M; prior year included $1.8M in discontinued products.","Loss from operations improved to $4.0M from $4.6M; operating expenses fell 29% to $5.6M.","Cost of revenues down to $825k from $3.5M, driving $922k gross profit improvement.","Private placement financing impact on net loss still under review; Q1 10-Q to be filed next week.","GoodWheat pasta named 'Best New Product' by Retail Dietitians Business Alliance."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-021303","json":"https://secwatch.observer/filing/0000950170-23-021303.json","markdown":"https://secwatch.observer/filing/0000950170-23-021303.md","text":"https://secwatch.observer/filing/0000950170-23-021303.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1469443/000095017023021303/0000950170-23-021303-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1469443/000095017023021303/rkda-20230511.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T03:58:00.075716+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b9e0c4ebb6f9031967419f994d4422c65c94e0bc","claim":"Arcadia Biosciences, Inc. reported financial results for first quarter ended March 31, 2023.","evidence_excerpt":"On May 11, 2023 Arcadia Biosciences, Inc. (the “Company”) issued a press release announcing financial results for the first quarter ended March 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1469443/000095017023021303/0000950170-23-021303-index.htm","confidence":0.5,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}